|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.9 TWD | 0.00% |
|
-2.35% | -16.30% |
GlycoNex Incorporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 30.09 million compared to TWD 5.48 million a year ago. Net loss was TWD 219.82 million compared to TWD 172.49 million a year ago.
Basic loss per share from continuing operations was TWD 2.21 compared to TWD 1.78 a year ago. Diluted loss per share from continuing operations was TWD 2.21 compared to TWD 1.78 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.30% | 83.68M | |
| +22.07% | 46.81B | |
| -0.85% | 41.37B | |
| +47.07% | 41.29B | |
| -3.52% | 28.87B | |
| +11.08% | 26.06B | |
| -19.02% | 19.13B | |
| +32.17% | 12.39B | |
| +0.31% | 12.08B | |
| +0.32% | 11.96B |
GLYCONEX INCORPORATION 